VitaNova Life Sciences (VNOV) EBITDA Margin Growth (1y) (2022 - 2026)
Analysis
VitaNova Life Sciences (VNOV) EBITDA Margin Growth (1y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 120.96 Bn | 111.91 Bn | 6.13 Bn | 14.00 |
| 2 | UL Solutions | 12.94 Bn | 12.53 Bn | 417.00 Mn | 47.00 |
| 3 | Gartner | 11.74 Bn | 10.25 Bn | 1.19 Bn | 288.00 |
| 4 | Booz Allen Hamilton Holding | 9.28 Bn | 8.74 Bn | 1.46 Bn | 117.00 |
| 5 | Tetra Tech | 9.14 Bn | 8.91 Bn | 243.21 Mn | 7.00 |
| 6 | Genpact | 5.74 Bn | 5.22 Bn | 490.34 Mn | 6.00 |
| 7 | Grand Canyon Education | 3.97 Bn | 3.69 Bn | 204.08 Mn | 110.00 |
| 8 | Fti Consulting | 3.91 Bn | 3.74 Bn | 316.27 Mn | -196.00 |
| 9 | Korn Ferry | 3.90 Bn | 3.09 Bn | 681.29 Mn | 55.00 |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.90 Mn | 30,521.00 | -677.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -6,156.00 |
| Jan 31, 2026 | -2,873.00 |
| Oct 31, 2025 | 179.00 |
| Jul 31, 2025 | 1,064.00 |
| Apr 30, 2025 | 1,268.00 |
| Jan 31, 2025 | 1,252.00 |
| Apr 30, 2024 | 18,889.00 |
| Jan 31, 2024 | 26,856.00 |
| Apr 30, 2023 | -8,660.00 |
| Jan 31, 2023 | -27,549.00 |
| Oct 31, 2022 | 9,266.00 |